Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Etoricoxib IP 60 mg + Serratiopeptidase IP 10 mg Tablet
Therapeutic Category
Anti-Inflammatories, Analgesics, Orthopedics
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹189/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Etoscrib SP Tablet contains Etoricoxib IP (60 mg), a selective COX-2 inhibitor that provides potent pain relief and reduces inflammation, along with Serratiopeptidase IP (10 mg), an enzyme that helps reduce swelling and promote healing. This combination is widely used in the management of painful inflammatory conditions, offering both symptomatic relief and faster recovery. It helps in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, post-operative pain, dental pain, and injury-related inflammation.
Possible side effects include heartburn, nausea, dizziness, headache, stomach discomfort, and swelling of the legs or feet. Rarely, it may cause serious cardiovascular or gastrointestinal events.
Used for the treatment of pain, inflammation, and swelling associated with arthritis, spondylitis, dental procedures, orthopedic injuries, and post-surgical recovery.
Should be taken only under medical supervision, especially in patients with heart, liver, kidney, or stomach-related problems. Avoid long-term use unless prescribed. Not suitable for pregnant or breastfeeding women unless advised by a doctor.
Store below 25°C. Protect from light and do not freeze. Keep out of reach of children.
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac (50mg) + Serratiopeptidase (10mg)
Composition : Chlorzoxazone (250mg) + Diclofenac (50mg) + Paracetamol (325mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Composition : Diclofenac diethylamine (1.16% w/w) + Linseed Oil (3% w/w) + Methyl Salicylate (10% w/w) + Menthol (0.5% w/w)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Diclofenac (100mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination is an anti-inflammatory and enzyme-based pain relief formulation used for swelling, pain, and tissue inflammation, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in arthritis, osteoarthritis, dental pain, post-operative swelling, sports injuries, and musculoskeletal inflammation. It is commonly prescribed by orthopedicians, dentists, and general physicians for pain relief with anti-swelling action.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Etoricoxib 60mg + Serratiopeptidase 10mg Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady orthopedic prescription demand, repeat usage in inflammation-related conditions, and strong acceptance in dental and surgical recovery segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-inflammatory combination formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.